Biglycan expression in the melanoma microenvironment promotes invasiveness via increased tissue stiffness inducing integrin-integrin-[beta]1expression
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Oncotarget. 8, 26 (2017), 42901-42916, DOI 10.18632/oncotarget.17160, issn: 1949-2553
- Schlagwort
-
Melanom
- Ereignis
-
Veröffentlichung
- (wo)
-
Freiburg
- (wer)
-
Universität
- (wann)
-
2018
- Urheber
-
Andrlová, Hana
Mastroianni, Justin
Madl, Josef
Kern, Johannes S.
Melchinger, Wolfgang
Dierbach, Heide
Wernet, Florian
Follo, Marie
Technau-Hafsi, Kristin
Has, Cristina
Mittapalli, Venugopal Rao
Idzko, Marco
Griffin, Ricarda
Brummer, Tilman
Ungefroren, Hendrik
Busch, Hauke
Börries, Melanie
Narr, Andreas
Ihorst, Gabriele
Vennin, Claire
Schmitt-Graeff, Annette
Minguet, Susana
Timpson, Paul
Duyster, Justus
Meiß, Frank
Römer, Winfried
Zeiser, Robert
- DOI
-
10.18632/oncotarget.17160
- URN
-
urn:nbn:de:bsz:25-freidok-159214
- Rechteinformation
-
Kein Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:44 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Andrlová, Hana
- Mastroianni, Justin
- Madl, Josef
- Kern, Johannes S.
- Melchinger, Wolfgang
- Dierbach, Heide
- Wernet, Florian
- Follo, Marie
- Technau-Hafsi, Kristin
- Has, Cristina
- Mittapalli, Venugopal Rao
- Idzko, Marco
- Griffin, Ricarda
- Brummer, Tilman
- Ungefroren, Hendrik
- Busch, Hauke
- Börries, Melanie
- Narr, Andreas
- Ihorst, Gabriele
- Vennin, Claire
- Schmitt-Graeff, Annette
- Minguet, Susana
- Timpson, Paul
- Duyster, Justus
- Meiß, Frank
- Römer, Winfried
- Zeiser, Robert
- Universität
Entstanden
- 2018
Ähnliche Objekte (12)
Advances in understanding the pathogenesis of graft‐versus‐host disease
The role of biglycan in the tumor microenvironment of malignant melanoma
Intestinal microbiota influence immune tolerance post allogeneic hematopoietic cell transplantation and intestinal GVHD
Editorial: Non-coding RNAs and graft versus host disease
Chimeric antigen receptor T cells for acute myeloid leukemia
Immunomodulatory therapies for the treatment of graft-versus-host disease
Immunotherapy in myeloproliferative diseases
The role of the MDM2/p53 axis in anti-tumor immune responses
Kinase inhibition as treatment for acute and chronic graft-versus-host disease
Editorial: Current concepts of cellular and biological drugs to modulate regulatory T cell activity in the clinic, volume II
FLT3-inhibitor therapy for prevention and treatment of relapse after allogeneic hematopoietic cell transplantation
Novel biomarkers for outcome after allogeneic hematopoietic stem cell transplantation
Advances in understanding the pathogenesis of graft‐versus‐host disease
The role of biglycan in the tumor microenvironment of malignant melanoma
Intestinal microbiota influence immune tolerance post allogeneic hematopoietic cell transplantation and intestinal GVHD
Editorial: Non-coding RNAs and graft versus host disease
Chimeric antigen receptor T cells for acute myeloid leukemia
Immunomodulatory therapies for the treatment of graft-versus-host disease
Immunotherapy in myeloproliferative diseases
The role of the MDM2/p53 axis in anti-tumor immune responses
Kinase inhibition as treatment for acute and chronic graft-versus-host disease
Editorial: Current concepts of cellular and biological drugs to modulate regulatory T cell activity in the clinic, volume II
FLT3-inhibitor therapy for prevention and treatment of relapse after allogeneic hematopoietic cell transplantation
Novel biomarkers for outcome after allogeneic hematopoietic stem cell transplantation
Advances in understanding the pathogenesis of graft‐versus‐host disease
The role of biglycan in the tumor microenvironment of malignant melanoma
Intestinal microbiota influence immune tolerance post allogeneic hematopoietic cell transplantation and intestinal GVHD
Editorial: Non-coding RNAs and graft versus host disease
Chimeric antigen receptor T cells for acute myeloid leukemia
Immunomodulatory therapies for the treatment of graft-versus-host disease
Immunotherapy in myeloproliferative diseases
The role of the MDM2/p53 axis in anti-tumor immune responses
Kinase inhibition as treatment for acute and chronic graft-versus-host disease
Editorial: Current concepts of cellular and biological drugs to modulate regulatory T cell activity in the clinic, volume II
FLT3-inhibitor therapy for prevention and treatment of relapse after allogeneic hematopoietic cell transplantation